ChemicalBook > CAS DataBase List > Ramucirumab
Ramucirumab
- Product Name
- Ramucirumab
- CAS No.
- 947687-13-0
- Chemical Name
- Ramucirumab
- Synonyms
- Cyramza;LY3009806;IMC-1121B;Ramucirumab;Ramucirumab (anti-VEGFR2);Ramucirumab,NSCLC,non–small-cell lung cancer,gastric cancer,Inhibitor,VEGFR,Vascular endothelial growth factor receptor,inhibit,angiogenesis inhibitor
- CBNumber
- CB72738188
- Formula Weight
- 0
- MOL File
- Mol file
More
Less
Ramucirumab Property
- storage temp.
- Store at -20°C
- solubility
- Soluble in DMSO
More
Less
Safety
- Hazardous Substances Data
- 947687-13-0(Hazardous Substances Data)
More
Less
N-Bromosuccinimide Price
ChemScene
- Product number
- CS-0031056
- Product name
- Ramucirumab
- Packaging
- 1mg
- Price
- $400
- Updated
- 2021/12/16
Biosynth Carbosynth
- Product number
- FR159043
- Product name
- Ramucirumab
- Packaging
- 1mg
- Price
- $425
- Updated
- 2021/12/16
American Custom Chemicals Corporation
- Product number
- ATB0023429
- Product name
- RAMUCIRUMAB
- Purity
- 95.00%
- Packaging
- 5MG
- Price
- $498.75
- Updated
- 2021/12/16
Biosynth Carbosynth
- Product number
- FR159043
- Product name
- Ramucirumab
- Packaging
- 2mg
- Price
- $650
- Updated
- 2021/12/16
Biosynth Carbosynth
- Product number
- FR159043
- Product name
- Ramucirumab
- Packaging
- 25mg
- Price
- $2150
- Updated
- 2021/12/16
More
Less
Ramucirumab Chemical Properties,Usage,Production
Clinical Use
Human monoclonal antibody:
Treatment of advanced gastric cancer or gastrooesophageal junction adenocarcinoma, colorectal
cancer and non-small cell lung cancer (NSLC)
target
VEGFR2
Drug interactions
Potentially hazardous interactions with other drugs
Vaccines: risk of generalised infections with live
vaccines - avoid.
Metabolism
The metabolism of ramucirumab has not been studied. Monoclonal antibodies are mainly cleared by catabolism.
Ramucirumab Preparation Products And Raw materials
Raw materials
Preparation Products
More
Less
Ramucirumab Suppliers
947687-13-0, RamucirumabRelated Search:
Adalimumab
Ustekinumab
Nivolumab
Bevacizumab
Daratumumab
OMALIZUMAB
Lambrolizumab
Dulaglutide
Infliximab
Rituximab
palivizumab
Immunoglobulin G4,anti-(human integrin R4) (human-mouse monoclonal AN100226 c4-chain),disulfide with human-mouse monoclonal AN100226 light chain,dimer
Atezolizumab
Denosumab
CETUXIMAB
Evolocumab
ipilimumab
Eculizumab